Imagen de Portada

PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Nicole Handa, Richard Bennett, Eric V. Li, Austin Ho, Mitchell M. Huang, Sai Kumar, Clayton Neill, Ridwan Alam, Hiten D. Patel, Edward M. Schaeffer, Ashley E. Ross
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	BJUI Compass
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
por: Austin Drysch, et al.
Publicado: (2025)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
por: Eric V. Li, et al.
Publicado: (2024)

Robotic radical prostatectomy in kidney transplant recipients: A propensity‐matched cohort study
por: Jennifer M. Slota, et al.
Publicado: (2025)

Contemporary assessment of diagnostic performance and histologic concordance of renal mass biopsy with surgical pathology
por: Mitchell M. Huang, et al.
Publicado: (2025)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
por: Jeremy Cheng, et al.
Publicado: (2025)

Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
por: Joshua Yi Min Tung, et al.
Publicado: (2026)

Anatomical distribution of disease in pN1 prostate cancer with BCR post‐RP: A PSMA‐PET/CT‐based analysis
por: Lotte G. Zuur, et al.
Publicado: (2025)

Utilization of cardiopulmonary bypass at radical nephrectomy for renal cell carcinoma with tumour thrombus
por: Chalairat Suk‐Ouichai, et al.
Publicado: (2024)

A population‐based analyses of the evolving management of cN1M0 prostate cancer in the PSMA‐PET era
por: Jennifer Ward, et al.
Publicado: (2025)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
por: Eric Margolis, et al.
Publicado: (2025)

Peak early‐phase enhancement ratio on contrast‐enhanced MRI to differentiate chromophobe renal cell carcinoma from oncocytoma
por: Deanna Thorson, et al.
Publicado: (2025)

National survey of urologists' views on prostate cancer screening in the United Kingdom
por: Nikhil Mayor, et al.
Publicado: (2026)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
por: Esther H. J. Hamoen, et al.
Publicado: (2025)

Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
por: Agnieszka Krzyzanowska, et al.
Publicado: (2024)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
por: Maxwell Louis Sandberg, et al.
Publicado: (2026)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
por: Sophia M. Abusamra, et al.
Publicado: (2025)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
por: Samantha Shekar, et al.
Publicado: (2025)

Cinematic rendering of 18 F‐DCFPyL PET/CT fusion data in a patient with metastatic clear cell renal cell carcinoma
por: Steven P. Rowe, et al.
Publicado: (2024)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
por: Ryan Sutherland, et al.
Publicado: (2024)

The carbon footprint of transperineal prostate biopsy
por: Daniel A. Carson, et al.
Publicado: (2025)

Emerging tools for the early detection of prostate cancer
por: Muhammad Haider, et al.
Publicado: (2025)

Targeted Prostate Health Checks, a novel system to identify men with prostate cancer—A pilot study
por: Stephen Langley, et al.
Publicado: (2024)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
por: Abel Tesfai, et al.
Publicado: (2024)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
por: Ansh Bhatia, et al.
Publicado: (2024)

Bibliometric analysis of focal therapy in prostate cancer research
por: Mohammed Shahait, et al.
Publicado: (2024)

Racial and socioeconomic disparities in surgical care for post‐prostate cancer treatment complications: A nationwide Medicare‐based analysis
por: Oluwafolajimi Adesanya, et al.
Publicado: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
por: Ailene E. Corona, et al.
Publicado: (2026)

The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
por: André B. Silva, et al.
Publicado: (2026)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
por: Mathew Thakur, et al.
Publicado: (2024)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
por: Nadia Rokan, et al.
Publicado: (2025)

Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia
por: Emilien Seizilles de Mazancourt, et al.
Publicado: (2025)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
por: Ruth Pidsley, et al.
Publicado: (2024)

WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
por: Mohamad Baker Berjaoui, et al.
Publicado: (2024)

Transperineal prostate biopsy with freehand technique under local anaesthetic: A systematic review and meta‐analysis
por: Benjamin M. Mac Curtain, et al.
Publicado: (2025)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
por: Geneva Pantoja, et al.
Publicado: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
por: Sofia Mesquita, et al.
Publicado: (2025)

Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
por: Lu Yu Kuo, et al.
Publicado: (2025)

Risk factors of negative prostate biopsies: A CHAID decision tree analysis
por: Pierre Allainguillaume, et al.
Publicado: (2026)

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
por: Stijn M. van den Bosch, et al.
Publicado: (2026)

A systematic review and network meta‐analysis comparing Rezūm with transurethral needle ablation and microwave thermotherapy for the management of enlarged prostate
por: Ansh Bhatia, et al.
Publicado: (2024)